Valtech Cardio Ltd., develops devices for the treatment of mitral valve regurgitation (MR), the most common heart valve disease. The company develops a range of products for transcatheter valve repair and replacement, based on the surgical gold standard, as well as repair products for open heart surgery that enable fine tuning on a beating heart. Valtech Cardio has full in-house development, manufacturing, quality assurance and clinical research capabilities and over 130 patents and patents applications. The company, comprised of multidisciplinary development teams, works in close collaboration with world renowned heart specialists to provide the best therapy a mitral patient can hope for.